The DOI matches its Crossref record; 141 of the 146 references it cites were found in a registry or an index, and 5 are not checked yet.
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Open accessAbstract
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly extended to become a global sanitary and economic emergency. Its etiological agent is the coronavirus SARS-CoV-2. COVID-19 presents a wide spectrum of clinical manifestations, which ranges from an asymptomatic infection to a severe pneumonia accompanied by multisystemic failure that can lead to a patient's death. The immune response to SARS-CoV-2 is known to involve all the components of the immune system that together appear responsible for viral elimination and recovery from the infection. Nonetheless, such immune responses are implicated in the disease's progression to a more severe and lethal process. This review describes the general aspects of both COVID-19 and its etiological agent SARS-CoV-2, stressing the similarities with other severe coronavirus infections, such as SARS and MERS, but more importantly, pointing toward the evidence supporting the hypothesis that the clinical spectrum of COVID-19 is a consequence of the corresponding variable spectrum of the immune responses to the virus. The critical point where progression of the disease ensues appears to center on loss of the immune regulation between protective and altered responses due to exacerbation of the inflammatory components. Finally, it appears possible to delineate certain major challenges deserving of exhaustive investigation to further understand COVID-19 immunopathogenesis, thus helping to design more effective diagnostic, therapeutic, and prophylactic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among them, IL-6 is a major player in chronic inflammatory diseases, autoimmune diseases, cancer and cytokine storm (1, 3, 10–26).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with the notion that severe COVID-19 is a cytokine storm syndrome (12–17, 336), the severity of COVID-19 is associated with an increased level of inflammatory cytokines, such as IL-6, granulocyte macrophage colony-stimulating factor (GM-CSF) and TNFα (333, 337).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ARDS in COVID-19 is considered the result of cytokine storm (12–17), resembling the disease caused by SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV) (335).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 162
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 740
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v14
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v13
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v24
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v18
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v17
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v8
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v29
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v34
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v22
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v27
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v23
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v34
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v12
Kashem, M. A., Li, L., Yuan, X.-Y., Plummer, F. A., & Luo, M. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s357866
Siregar, K. B., Azrah, A., & Aryanti, C. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9116
Overview of SARS-CoV-2 and Possible Targets for the Management of COVID-19 Infections
Muthuraman, A., Ramesh, M., Subramanian, A., Dhamodharan, J., & Giap, L. K. (2022) · Coronaviruses · doi:10.2174/2666796703666220623090158
Machine learning to predict intubation in COVID-19 patients
Hamdar, H. (2022) · Journal of Clinical Case Reports and Studies · doi:10.31579/2690-8808/124
Indexes of innate and adaptive immunity in the patients with SARS-CoV-2 infection
Sitdikova, T. S., Kabieva, A. A., & Prosekova, E. V. (2021) · Russian Journal of Immunology · doi:10.46235/1028-7221-1051-ioi
Balcı, U., Sarıgül, F., Seyman, D., Tahmaz, A., Keski̇n, A. S., ÖNDER, K. D., Berk, H., User, Ü., & Kızılateş, F. (2022) · Van Medical Journal · doi:10.5505/vtd.2022.00908
SARS-CoV-2 entry route impacts a range of downstream viral and cellular processesPreprint
Qu, B., Miskey, C., Gömer, A., Potmus, D., Nocke, M. K., Kleinert, R. D. V., Itotia, T. K., Valder, L., Brückmann, J., Höck, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.05.502936 · Cited by 1
Yu, L. (2022) · International Journal of Clinical Images and Medical Reviews · doi:10.55920/ijcimr.2022.02.001061
COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors
Guo, M., Liu, J., Zhou, S., Yu, J. B., Ahmed, Z., Ahmad, S., Manoucheri, M., Socinski, M. A., Mekhail, T. M., & Hsu, V. P. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01277-z
Edem, E. N. (2021) · Virology & Immunology Journal · doi:10.23880/vij-16000270
Jain, S., Bhowmick, A., & Pandey, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.962057
Habib, S., Farzana, I., Akther, T., & Nessa, A. (2022) · doi:10.22541/au.166871560.02594959/v1
Habib, S., Farzana, I., Akther, T., & Nessa, A. (2022) · doi:10.22541/au.166871560.02594959/v2
Neto, C. A., Bueno, K. F., Rabelo, R. Q., & Gomes, J. M. (2022) · Research Society and Development · doi:10.33448/rsd-v11i16.37936
Castillo-Aguilar, M., Aguilar, V. J. C., Alvarado-Aravena, C., Yáñez-Yáñez, R., Espinoza, Z. E. L., & Cigarroa, I. (2022) · Salud Uninorte · doi:10.14482/sun.38.3.616.24
Mortality Risk Factors Among Hospitalized Older Patients With COVID-19
Abdollahi, F., Rad, M. K., Mirzapour, M., Yekta, M. R., Alimohammadiha, A., Nouri, M., & Motalebi, S. A. (2021) · The Journal of Qazvin University of Medical Sciences · doi:10.32598/jqums.25.3.6
Cabrera, M., Salazar-Viedma, M., & D’Afonseca, V. (2022) · Genetics and Molecular Research · doi:10.4238/gmr19003
Real-Life Toxicants as an Emerging Challenge in the Rehabilitation of COVID-19 Survivors
Dizaji, R. (2022) · Journal of Human Environment and Health Promotion · doi:10.52547/jhehp.8.2.69
Abdussalam, M., Ganesh Kumar, P., Ismail, H. M., Shaikh, S., Ameer, B. R., & Salam, M. A. (2022) · International Journal of Advanced Biochemistry Research · doi:10.33545/26174693.2022.v6.i2b.150
El hemograma como predictor en la infección por SARS-CoV-2
Maya, G. C. (2022) · Medicina · doi:10.56050/01205498.1666
Complement system as the potential therapeutic target in the management of COVID-19 patients
Parsamanesh, G., Farhangnia, P., Karimi, M., Ghomi, A.-H. K., Dehrouyeh, S., & Aghamajidi, A. (2022) · Trends in Immunotherapy · doi:10.24294/ti.v6.i2.1834
Procalcitonin and C-Reactive protein levels among COVID-19 patients in Sulaymaniyah
(2023) · Muthanna Medical Journal · doi:10.52113/1/1/2023-14-37
Beyond the Disease: The Socioeconomic Drama of the Covid-19 Pandemic
Auriemma, V., Cafaro, D., Pelati, A., & Saladino, V. (2023) · Springer eBooks · doi:10.1007/978-3-030-96778-9_74-1
COVID-19 in patients with Systemic Lupus Erythematosus and the antiphospholipid syndrome
Crisafulli, F., Della-Pina, S.-E.-L., Fontana, G., Rodrigues-Fernandes, J.-M., Franceschini, F., Andréoli, L., & Tincani, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00003-7
THE WITHIN-HOST VIRAL KINETICS OF SARS-COV-2
Wang, M., Zhao, Y., Zhang, C., & Lou, J. (2023) · Journal of Applied Analysis & Computation · doi:10.11948/20220389
Karigoudar, R. M., Wavare, S. M., Karigoudar, M. H., Bagali, S., Shahapur, P. R., & Kakhandki, L. S. (2022) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_230_22
Aghazadeh, Z., Delir, D. S., Gholamrezaie, H. R., Sadoughi, A., Asl, A. N., Sanami, M. N., Gorabi, A. M., Panahi, Y., Taeb, M., Razavi, A., et al. (2023) · Current Drug Discovery Technologies · doi:10.2174/1570163820666230418095115
Total remission of Merkel cell carcinoma after Coronavirus infection: a case report
Vidoto, L. H. R., Martins, C. L. C., & de Melo, A. C. (2023) · Brazilian Journal of Oncology · doi:10.5935/2526-8732.20230404
Ahmed, T., Hasan, S. M. T., Akter, A., Tauheed, I., Akhtar, M., Rahman, S. I. A., Bhuiyan, T. R., Ahmed, T., Qadri, F., & Chowdhury, F. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1111037
Protection of SARS-CoV-2 trial vaccines in human is a function of the viral genomes
Saganuwan, S. A. (2023) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqad020
Resistensi Sosial terhadap Vaksinasi Covid 19 di Kabupaten Jeneponto
Haris, H., Kurniawan, R. N., & Wijaya, I. (2023) · Media Publikasi Promosi Kesehatan Indonesia (MPPKI) · doi:10.56338/mppki.v6i3.2912
The therapeutic potential of mesenchymal stem cells in COVID-19: Present and future
Sari, M. I., Putra, I. B., & Wijaya, D. W. (2023) · Research Results in Pharmacology · doi:10.18413/rrpharmacology.9.10031
Ahmed, T., Akter, A., Tauheed, I., Akhtar, M., Rahman, S. I. A., Khaton, F., Ahmmed, F., Firoj, M. G., Ferdous, J., Afrad, M. H., et al. (2023) · Medicina · doi:10.3390/medicina59071280
Kolben, Y., Finkelshtein, E., Code Pharma, T. N., Naftali, E., Code Pharma, T. N., Kenig, A., Kessler, A., Cardoso, F., Lisovoder, N., Code Pharma, T. N., et al. (2022) · Discoveries · doi:10.15190/d.2022.17
Vicente Hipólito, J. K. (2022) · Universidad Privada San Juan Bautista · doi:10.59590/upsjb/fcs.med.hum/tesis/3793
Anjali, M. S., & Raghavendra, B. S. (2023) · International Journal of Research and Review · doi:10.52403/ijrr.20230895
Habib, S., Farzana, I., Akther, T., & Nessa, A. (2023) · doi:10.22541/au.166871560.02594959/v3
Nemah, N. W., Jafar, N. A.-H., & Issa, S. B. (2023) · Tikrit Journal of Veterinary Sciences · doi:10.25130/tjvs.23.1.9
Modelo de ensamble para predecir el diagnóstico de pacientes con sospecha de Covid-19
Andrade-Girón, D., Sandivar-Rosas, J., & Carreño-Cisneros, E. (2023) · doi:10.31876/rcs.v29i.40973
Ribavirin Plus Therapy in Covid-19-A Single-Center Experience
Singh, B. O., Chikara, G., Panda, P. K., Bahurupi, Y. A., Saha, S., & Pai, V. S. (2023) · American Journal of Pharmacology and Toxicology · doi:10.3844/ajptsp.2023.1.7 · Cited by 1
Sadeg, A., & al-Tamimi, A. A. A. (2023) · Bionatura · doi:10.21931/rb/css/2023.08.03.91
Saldaña, A. S., Gil-Sánchez, A., González‐Mingot, C., Peralta, S., Solana, M. J., Torres, P., Juanes-Casado, A., Quibus, L., Ruiz, E., Sanpedro, E., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237243
Palma, A., Niño-Huertas, A., Bendezú-Quispe, G., & Herrera‐Añazco, P. (2023) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2023.404.12957
Mousaviasl, S., Sayar, S., Radmanesh, E., Pahlavanzadeh, B., Esmaeilian, H., Ebrahimzadeh, M., Tabahfar, R., Khalili, S. M., Borzoo, T., Jelvay, S., et al. (2023) · Disease and Diagnosis · doi:10.34172/ddj.500
Stratton, C. W., & Tang, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00053-8
Therapeutic landscape of SARS-CoV-2
Pandey, V. P., Sharma, S., Singh, V., Yadav, B. K., & Pokharel, Y. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95545-4.00020-7
Association of COVID with Mycosis in General
Kaur, G., Kaur, R., Sumanpreet, & Kaur, M. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265266815231130063931
Aspectos cardiovasculares na infecção por COVID-19
Cassimiro, R. D., Vaz, I. C. O. G., Santos, A. M. D. S., Cardoso, H. C., & Soares, V. (2022) · Brasília Médica · doi:10.5935/2236-5117.2022v59a60
Comparison of different techniques for evaluation of cellular immunity to SARS-CoV-2 virus
Afridonova, Z. E., Топтыгина, А. П., Васильевна, Б. А., & Semikina, E. L. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-cod-2640
Re-positive nucleic acid test in COVID-19 Patients: A systematic reviewPreprint
Nowroozi, A. A., Karimi, A., Alilou, S., Khalili, N., & Rezaei, N. (2024) · doi:10.22541/au.170664754.42527069/v1
Modelo de predicción temprana de infección sobreagregada en pacientes COVID-19 al ingreso a hospital
Ríos-Jaimes, F., Monzón-Lores, J. R., Villarreal-Rı́os, E., Terrazas-Galindo, K. L., & Ramírez-Sánchez, M. (2024) · Revista de Educaci�n e Investigaci�n en Emergencias · doi:10.24875/reie.23000017
Арьев, А. Л., & Лаптева, Е. С. (2024) · Успехи геронтологии · doi:10.34922/ae.2023.36.6.006
COVID-19: dinâmica de citocinas dos perfis Th1, Th2 e Th17 em pacientes oligossintomáticos
Savino, B. A. C., Costa, I. B., Nunes, J. A. L., de Oliveira, C. F., das Chagas, W. D., da Penha, E. T., Henriques, D. F., & Costa, I. B. (2024) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv22n3-064
Karim, Q. A., Baum, F. E., & Detels, R. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198816805.002.0013
Guzmán, D. T., Delgado, A. M. D. O., & Morales, E. B. (2024) · Research Square · doi:10.21203/rs.3.rs-4172309/v1
Polyakov, Y. Y., Baryakh, E. A., Misyurina, E. N., Zhelnova, E. I., Mingalimov, M. A., Kardovskaya, S. A., Smolyarchuk, M. Y., Толстых, Т. Н., Чуднова, Т. С., Иванова, Д. Д., et al. (2024) · Oncohematology · doi:10.17650/1818-8346-2024-19-2-101-108
The pathophysiology of COVID-19 and the cardiovascular system
Ahsan, N., Adesida, M. O., Memon, N., & Obemaier, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19091-9.00014-7
El-Menyar, A. A., Khan, N. A., Asim, M., Al-Thani, H. A. S., Abukhattab, M., & Maslamani, M. A. R. S. A. (2024) · F1000Research · doi:10.12688/f1000research.146814.1
Kayani, U. T., Sidhwani, S. K., Khatoon, A., Kumar, A. J., & Mirza, T. (2024) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs02023171223
Systems Biology and Human Diseases
Jasmine, R., Soundararajan, S., Rosita, A. S., & Priscilla, H. D. (2024) · Springer eBooks · doi:10.1007/978-981-99-9462-5_2
Vasilieva, I., Vasilieva, M., & Vasiliev, I. (2024) · Special journal of the Medical Academy and other Life Sciences · doi:10.58676/sjmas.v2i4.70
Ramalan, M. A., Musa, B. M., Rabiu, A. A., Abdullahi, A., & Damagum, F. M. (2023) · Nigerian Journal of Medicine · doi:10.4103/njm.njm_102_23
Duarte, T., Omage, F. B., Rieder, G. S., da Rocha, J. B. T., & Corte, C. L. D. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167324
Venkatesan, B., Vajravelu, L. K., Ravi, S., Thulukanam, J., & Muthamilan, O. L. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.3.05
Emerging immunological challenges in post-COVID individuals: insights from a case series and review
Karmakar, S., & Sharma, P. (2024) · Chest Disease Reports · doi:10.4081/cdr.12.12659
Clinical relationship between reactive arthritis and SARS-CoV-2 infection: A scoping review
Tuta-Quintero, E., Santacruz, J. C., Camacho, J., Olivella, J., Collazos, E., Gómez, J. C., Ochoa, D. A., Salazar-Villa, J., Rodríguez, J. E., Pérez, D. F., et al. (2024) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2023.04.001
Goyal, A., Singh, O., & Juneja, D. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0613
Microbiota-Based Therapeutics for COVID-19 and Sequelae
de Oliveira, G. L. V. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_22
Cytokine Storm in Pathogenesis of COVID-19 Complications
Rasputniak, O. V., Гавриленко, Т. И., Pidgaina, O. A., Shnaider, L. M., Lomakovskyi, O. M., & Kalashnikov, S. A. (2024) · Ukrainian journal of cardiovascular surgery · doi:10.30702/ujcvs/24.32(03)/rg042-7384
Calcaterra, V., Santis, R. D., Braghieri, D., Zanelli, S., & Zuccotti, G. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1456545 · Cited by 1
Lashkari, M., Kariminik, A., & Banavandi, M. J. S. (2024) · Journal of Kermanshah University of Medical Sciences · doi:10.5812/jkums-145333
PANoptosis as a Therapeutic Target for COVID-19
Si, Y., Zhu, X., Zhang, Y., Zhou, Z., Liu, Y., & Ma, H. (2026) · Current Microbiology · doi:10.1007/s00284-026-04950-x
The Severity of COVID-19 in Systemic Lupus Erythematosus Patient
Danao, K. R., Rokde, V. V., & Mahajan, U. N. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265326851241115072224
Turan, A., Öğüt, H., Bozkurt, H., & Varol, A. A. (2025) · The European Research Journal · doi:10.18621/eurj.1599508
Guercetti, J., Alorda, M., Sappia, L. D., Galvé, R., Duran-Corbera, M., Pulido, D., Berardi, G., Royo, M., Lacoma, A., Muñoz, J., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00727
Does knee joint arthropathy exist post-COVID-19 in the long term? A cross-sectional study
Ahmed, M. M., Zaino, M. R., OTHMAN, A., Hassan, A. Z. I., Arishi, A. A., OTAYF, R., KHURAYZI, R. H., AMER, A. M. A., & Amin, W. M. (2025) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.24.05554-2
The Effect of Antioxidants on COVID-19 Pneumonia: Managements and Future Strategies
Taghavinejad, H., Aleebrahim‐Dehkordi, E., Ghaderi, M., Dehkordi, A. H., Dehkordi, A. H., Mirfendereski, S., & Ahmadnia, M. (2025) · Coronaviruses · doi:10.2174/0126667975346902250308075212
EFFICIENCY AND SAFETY OF EXOSOMES TREATMENT IN SARS-COV-2 CAUSED INFECTIOUS DISEASES
BUDASH, G., & Bilko, N. (2025) · Bulletin of Taras Shevchenko National University of Kyiv Series “Psychology” · doi:10.17721/1728.2748.2025.100.15-25
Ahammad, S., Akter, R., Koddus, M. A., Hossain, M. K., Rahman, E., Hossain, T., Islam, M. M., Yin, K. N., Kabir, M. F., & Jahid, I. K. (2025) · Discover Public Health · doi:10.1186/s12982-025-00712-5
El-Menyar, A. A., Khan, N. A., Asim, M., Al-Thani, H. A. S., Abukhattab, M., & Maslamani, M. A. R. S. A. (2025) · F1000Research · doi:10.12688/f1000research.146814.2
Борисович, П. С., Davydova, N. V., & Казаков, С. П. (2025) · Medical Immunology (Russia) · doi:10.15789/1563-0625-spo-3236
Zhuo, X., Meng, J., & Chen, G. (2025) · Medicine · doi:10.1097/md.0000000000045481
Li, S., & Hua, X. (2021) · Figshare · doi:10.6084/m9.figshare.13710712
Li, S., & Hua, X. (2021) · Figshare · doi:10.6084/m9.figshare.13710634
Metadata
- Authors
- García, L. F.
- Affiliations
- Universidad de Antioquia (CO)
- Corresponding author
- García, Luis F.
- ORCID
- García, Luis F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-16
- Volume
- 11
- Pages
- 1441-1441
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC7308593
- OpenAlex
- W3035895802
- Cited by
- 739
- References
- 141
- Citations by year
- 2026: 17 · 2025: 30 · 2024: 68 · 2023: 89 · 2022: 172 · 2021: 279 · 2020: 83
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, immune response, inflammation, clinical spectrum, immunopathogenesis, disease severity, SARS, MERS, immune regulation, coronavirus infection
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Age Factors, Antibodies, Viral, Humans, Immunoglobulin A, Secretory, Inflammation, Macrophages, Pneumonia, Viral, T-Lymphocytes, Cytokines, Coronavirus Infections, Antibody-Dependent Enhancement, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
